Gabriel Aughey,Elisa Cali,Reza Maroofian,Maha S Zaki,Alistair T Pagnamenta,Fatima Rahman,Lara Menzies,Anum Shafique,Mohnish Suri,Emmanuel Roze,Mohammed Aguennouz,Zouiri Ghizlane,Saadia Maryam Saadi,Zafar Ali,Uzma Abdulllah,Huma Arshad Cheema,Muhammad Nadeem Anjum,Godelieve Morel,Robert McFarland,Umut Altunoglu,Verena Kraus,Moneef Shoukier,David Murphy,Kristina Flemming,Hilde Yttervik,Hajar Rhouda,Gaetan Lesca,Bibi Nazia Murtaza,Mujaddad Ur Rehman,SYNAPS Study Group,Genomics England Consortium,Go Hun Seo,Christian Beetz,Hülya Kayserili,Yamna Krioulie,Wendy K Chung,Sadaf Naz,Shazia Maqbool,Joseph Gleeson,Shahid Mahmood Baig,Stephanie Efthymiou,Jenny C Taylor,Mariasavina Severino,James EC Jepson,Henry Houlden

Abstract:Retinoblastoma (RB) proteins are highly conserved transcriptional regulators that play important roles during development by regulating cell-cycle gene expression. RBL2 dysfunction has been linked to a severe neurodevelopmental disorder. However, to date, clinical features have only been described in six individuals carrying five biallelic predicted loss of function (pLOF) variants. To define the phenotypic effects of mutations in detail, we identified and clinically characterized a cohort of 28 patients from 18 families carrying LOF variants in , including fourteen new variants that substantially broaden the molecular spectrum. The clinical presentation of affected individuals is characterized by a range of neurological and developmental abnormalities. Global developmental delay and intellectual disability were uniformly observed, ranging from moderate to profound and involving lack of acquisition of key motor and speech milestones in most patients. Frequent features included postnatal microcephaly, infantile hypotonia, aggressive behaviour, stereotypic movements and non-specific dysmorphic features. Common neuroimaging features were cerebral atrophy, white matter volume loss, corpus callosum hypoplasia and cerebellar atrophy. In parallel, we used the fruit fly, , to investigate how disruption of the conserved RBL2 orthologueue Rbf impacts nervous system function and development. We found that LOF mutants recapitulate several features of patients harboring variants, including alterations in the head and brain morphology reminiscent of microcephaly, and perturbed locomotor behaviour. Surprisingly, in addition to its known role in controlling tissue growth during development, we find that continued expression is also required in fully differentiated post-mitotic neurons for normal locomotion in , and that adult-stage neuronal re-expression of is sufficient to rescue mutant locomotor defects. Taken together, this study provides a clinical and experimental basis to understand genotype-phenotype correlations in an -linked neurodevelopmental disorder and suggests that restoring expression through gene therapy approaches may ameliorate aspects of LOF patient symptoms.

The first case of a point pathogenic variant in the RREB1 gene in Noonan‐like Rasopathy

Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11

Loss of function NOG variant causes radiounlar synostosis

Functional analysis of RRAS2 pathogenic variants with a Noonan-like phenotype

Noonan syndrome‐like phenotype associated with an ERF frameshift variant

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes

Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome

Case report: A de novo RASopathy-causing SHOC2 variant in a Chinese girl with noonan syndrome-like with loose anagen hair

New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients

Novel frameshift Variant c.3056delA of the DHX38 Gene in a Chinese Family With Retinitis Pigmentosa

Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders

A second RUBCN variant associated with epileptic encephalopathy and neurodevelopmental delay

Re‐analysis of whole genome sequencing ends a diagnostic odyssey: Case report of an RNU4‐2 related neurodevelopmental disorder

A milder form of NSRP1‐associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal

RASopathies Due to De Novo Pathogenic Variants: Clinical Features, Genetic Findings and Outcomes in Nine Neonates Born with Congenital Heart Defects

A Novel Autosomal Recessive Candidate Gene Responsible for RASopathy-Like Phenotype and Bone Marrow Failure: RASA3

A novel de novo synonymous variant in GREB1L impacts the mRNA splicing associated with aplasia of the urogenital system

New COL6A6 variant detected by whole-exome sequencing is linked to break points in intron 4 and 3'-UTR, deleting exon 5 of RHO, and causing adRP

Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorder

Novel Pathogenic Variants in the RECQL4 Gene Causing Rothmund‐Thomson Syndrome in Three Chinese Patients